To access this element change to forms mode OFF
Grant Award View - GA204249
Engineering of novel insulin analogues for improved management of...
GA ID:
GA204249
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
6-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$1,098,388.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Engineering of novel insulin analogues for improved management of diabetes
Purpose:
Diabetes is a major global health condition affecting nearly 0.5 billion people. Insulin is an essential treatment for Type 1 and, increasingly, Type 2 diabetes. However, it is difficult to both manufacture and handle as it aggregates rapidly in solution making storage and accurate dosing difficult. We will develop novel modified insulins that are biologically active, long-acting, aggregate-free and which self-respond to increases in glucose levels therefore greatly improving diabetes therapy.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2010781
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC, SA
Postcode:
Multiple
Country:
AUSTRALIA